MiRagen Therapeutics Receives $8,499,962 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c5a7fc7f-bc54-43da-be19-4b50a471324b
Date
2/18/2015
Company Name
MiRagen Therapeutics
Mailing Address
6200 Lookout Rd Boulder, CO 80301 USA
Company Description
Miragen was founded in 2007 to exploit recent discoveries showing that specific perturbations in microRNA expression are correlated with various forms of cardiovascular disease.
Website
http://www.miragentherapeutics.com
Transaction Type
Debt
Transaction Amount
$8,499,962
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor